{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:47:06Z","timestamp":1791780426722,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12901-9","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:26:10Z","timestamp":1791779170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SREBF1 expression is associated with lipid metabolism-related signatures, and transient SREBF1 silencing is accompanied by increased apoptosis in pancreatic cancer cells"],"prefix":"10.1007","volume":"53","author":[{"given":"Jiayi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danlei","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kequn","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"issue":"1","key":"12901_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"key":"12901_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","volume":"18","author":"MH Sherman","year":"2023","unstructured":"Sherman MH, Beatty GL (2023) Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance. Annu Rev Pathol 18:123\u2013148. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-031621-024600","journal-title":"Annu Rev Pathol"},{"key":"12901_CR3","doi-asserted-by":"publisher","first-page":"217699","DOI":"10.1016\/j.canlet.2025.217699","volume":"622","author":"K Br\u00e4utigam","year":"2025","unstructured":"Br\u00e4utigam K, Skok K, Szymonski K, Rift CV, Karamitopoulou E (2025) Tumor immune microenvironment in pancreatic ductal adenocarcinoma revisited - Exploring the Space. Cancer Lett 622:217699. https:\/\/doi.org\/10.1016\/j.canlet.2025.217699","journal-title":"Cancer Lett"},{"issue":"18","key":"12901_CR4","doi-asserted-by":"publisher","first-page":"e184846","DOI":"10.1172\/JCI184846","volume":"134","author":"M Bicak","year":"2024","unstructured":"Bicak M, Cimen Bozkus C, Bhardwaj N (2024) Checkpoint therapy in cancer treatment: progress, challenges, and future directions. J Clin Invest 134(18):e184846. https:\/\/doi.org\/10.1172\/JCI184846","journal-title":"J Clin Invest"},{"issue":"1","key":"12901_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1158\/1535-7163.MCT-24-0311","volume":"24","author":"EF Giurini","year":"2025","unstructured":"Giurini EF, Ralph O, Pappas SG, Gupta KH (2025) Looking Beyond Checkpoint Inhibitor Monotherapy: Uncovering New Frontiers for Pancreatic Cancer Immunotherapy. Mol Cancer Ther 24(1):18\u201332. https:\/\/doi.org\/10.1158\/1535-7163.MCT-24-0311","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"12901_CR6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41392-023-01522-4","volume":"8","author":"Q Sun","year":"2023","unstructured":"Sun Q, Hong Z, Zhang C, Wang L, Han Z, Ma D (2023) Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends. Signal Transduct Target Ther 8(1):320. https:\/\/doi.org\/10.1038\/s41392-023-01522-4","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"12901_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s42255-020-00317-z","volume":"3","author":"I Elia","year":"2021","unstructured":"Elia I, Haigis MC (2021) Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism. Nat Metab 3(1):21\u201332. https:\/\/doi.org\/10.1038\/s42255-020-00317-z","journal-title":"Nat Metab"},{"issue":"12","key":"12901_CR8","doi-asserted-by":"publisher","first-page":"115064","DOI":"10.1016\/j.celrep.2024.115064","volume":"43","author":"Y Mao","year":"2024","unstructured":"Mao Y, Xia Z, Xia W, Jiang P (2024) Metabolic reprogramming, sensing, and cancer therapy. Cell Rep 43(12):115064. https:\/\/doi.org\/10.1016\/j.celrep.2024.115064","journal-title":"Cell Rep"},{"issue":"3","key":"12901_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova NN, Zhu J, Thompson CB (2022) The hallmarks of cancer metabolism: Still emerging. Cell Metab 34(3):355\u2013377. https:\/\/doi.org\/10.1016\/j.cmet.2022.01.007","journal-title":"Cell Metab"},{"issue":"1","key":"12901_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s43018-023-00702-z","volume":"5","author":"FCE Vogel","year":"2024","unstructured":"Vogel FCE, Chaves-Filho AB, Schulze A (2024) Lipids as mediators of cancer progression and metastasis. Nat Cancer 5(1):16\u201329. https:\/\/doi.org\/10.1038\/s43018-023-00702-z","journal-title":"Nat Cancer"},{"issue":"1","key":"12901_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41419-026-08439-0","volume":"17","author":"J Wang","year":"2026","unstructured":"Wang J, Zhang L, Chen K et al (2026) c-Myc\/GRPEL1 maintains fatty acid synthesis via FASN to support PDAC cell proliferation. Cell Death Dis 17(1):205. https:\/\/doi.org\/10.1038\/s41419-026-08439-0","journal-title":"Cell Death Dis"},{"issue":"5","key":"12901_CR12","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3724\/abbs.2023066","volume":"55","author":"R Xu","year":"2023","unstructured":"Xu R, Liu Y, Ma L et al (2023) NQO1\/CPT1A promotes the progression of pancreatic adenocarcinoma via fatty acid oxidation. Acta Biochim Biophys Sin (Shanghai) 55(5):758\u2013768. https:\/\/doi.org\/10.3724\/abbs.2023066","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"10","key":"12901_CR13","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.devcel.2021.04.013","volume":"56","author":"LA Broadfield","year":"2021","unstructured":"Broadfield LA, Pane AA, Talebi A, Swinnen JV, Fendt SM (2021) Lipid metabolism in cancer: New perspectives and emerging mechanisms. Dev Cell 56(10):1363\u20131393. https:\/\/doi.org\/10.1016\/j.devcel.2021.04.013","journal-title":"Dev Cell"},{"issue":"4","key":"12901_CR14","doi-asserted-by":"publisher","first-page":"100987","DOI":"10.1016\/j.gendis.2023.04.022","volume":"11","author":"Y He","year":"2023","unstructured":"He Y, Qi S, Chen L et al (2023) The roles and mechanisms of SREBP1 in cancer development and drug response. Genes Dis 11(4):100987. https:\/\/doi.org\/10.1016\/j.gendis.2023.04.022","journal-title":"Genes Dis"},{"issue":"2","key":"12901_CR15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10555-023-10156-5","volume":"43","author":"F Su","year":"2024","unstructured":"Su F, Koeberle A (2024) Regulation and targeting of SREBP-1 in hepatocellular carcinoma. Cancer Metastasis Rev 43(2):673\u2013708. https:\/\/doi.org\/10.1007\/s10555-023-10156-5","journal-title":"Cancer Metastasis Rev"},{"issue":"13","key":"12901_CR16","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.7150\/jca.114356","volume":"16","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Cai X, Gong Y et al (2025) SREBP1-SCD1 enhanced MUFAs Biosynthesis drives Nutrient Deprived Pancreatic cancer cell Ferroptosis Resistance. J Cancer 16(13):3960\u20133971. https:\/\/doi.org\/10.7150\/jca.114356","journal-title":"J Cancer"},{"issue":"1","key":"12901_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13062-025-00595-1","volume":"20","author":"C Zhou","year":"2025","unstructured":"Zhou C, Feng Z, Qian W et al (2025) Elevated SREBP1 accelerates the initiation and growth of pancreatic cancer by targeting SOX9. Biol Direct 20(1):6. https:\/\/doi.org\/10.1186\/s13062-025-00595-1","journal-title":"Biol Direct"},{"issue":"1","key":"12901_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12967-023-04822-z","volume":"22","author":"Z Wang","year":"2024","unstructured":"Wang Z, Chao Z, Wang Q et al (2024) EXO1\/P53\/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression. J Transl Med 22(1):104. https:\/\/doi.org\/10.1186\/s12967-023-04822-z","journal-title":"J Transl Med"},{"issue":"9","key":"12901_CR19","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1158\/2767-9764.CRC-24-0120","volume":"4","author":"CT Ishida","year":"2024","unstructured":"Ishida CT, Myers SL, Shao W et al (2024) SREBP-dependent regulation of lipid homeostasis is required for progression and growth of pancreatic ductal adenocarcinoma. Cancer Res Commun 4(9):2539\u20132552. https:\/\/doi.org\/10.1158\/2767-9764.CRC-24-0120","journal-title":"Cancer Res Commun"},{"issue":"40","key":"12901_CR20","doi-asserted-by":"publisher","first-page":"e2407069","DOI":"10.1002\/advs.202407069","volume":"11","author":"YH Shi","year":"2024","unstructured":"Shi YH, Liu ZD, Ma MJ et al (2024) Platelet-Derived Growth Factor C Facilitates Malignant Behavior of Pancreatic Ductal Adenocarcinoma by Regulating SREBP1 Mediated Lipid Metabolism. Adv Sci (Weinh) 11(40):e2407069. https:\/\/doi.org\/10.1002\/advs.202407069","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"12901_CR21","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/s41571-025-01077-z","volume":"22","author":"HC Kung","year":"2025","unstructured":"Kung HC, Zheng KW, Zimmerman JW, Zheng L (2025) The tumour microenvironment in pancreatic cancer - new clinical challenges, but more opportunities. Nat Rev Clin Oncol 22(12):969\u2013995. https:\/\/doi.org\/10.1038\/s41571-025-01077-z","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"12901_CR22","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41419-024-06930-0","volume":"15","author":"H Wu","year":"2024","unstructured":"Wu H, Fu M, Wu M, Cao Z, Zhang Q, Liu Z (2024) Emerging mechanisms and promising approaches in pancreatic cancer metabolism. Cell Death Dis 15(8):553. https:\/\/doi.org\/10.1038\/s41419-024-06930-0","journal-title":"Cell Death Dis"},{"issue":"6","key":"12901_CR23","doi-asserted-by":"publisher","first-page":"112681","DOI":"10.1016\/j.isci.2025.112681","volume":"28","author":"H Wu","year":"2025","unstructured":"Wu H, Zhang Q, Cao Z et al (2025) Integrated spatial omics of metabolic reprogramming and the tumor microenvironment in pancreatic cancer. iScience 28(6):112681. https:\/\/doi.org\/10.1016\/j.isci.2025.112681","journal-title":"iScience"},{"issue":"2","key":"12901_CR24","doi-asserted-by":"publisher","first-page":"159578","DOI":"10.1016\/j.bbalip.2024.159578","volume":"1870","author":"T Daya","year":"2025","unstructured":"Daya T, Breytenbach A, Gu L, Kaur M (2025) Cholesterol metabolism in pancreatic cancer and associated therapeutic strategies. Biochim Biophys Acta Mol Cell Biol Lipids 1870(2):159578. https:\/\/doi.org\/10.1016\/j.bbalip.2024.159578","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"1","key":"12901_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12944-024-02426-0","volume":"24","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Yang Z, Liu Y, Pei J, Li R, Yang Y (2025) Targeting lipid metabolism: novel insights and therapeutic advances in pancreatic cancer treatment. Lipids Health Dis 24(1):12. https:\/\/doi.org\/10.1186\/s12944-024-02426-0","journal-title":"Lipids Health Dis"},{"issue":"11","key":"12901_CR26","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.cmet.2022.09.023","volume":"34","author":"M Martin-Perez","year":"2022","unstructured":"Martin-Perez M, Urdiroz-Urricelqui U, Bigas C, Benitah SA (2022) The role of lipids in cancer progression and metastasis. Cell Metab 34(11):1675\u20131699. https:\/\/doi.org\/10.1016\/j.cmet.2022.09.023","journal-title":"Cell Metab"},{"issue":"8068","key":"12901_CR27","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41586-025-08917-z","volume":"642","author":"C Cheng","year":"2025","unstructured":"Cheng C, Hu J, Mannan R et al (2025) Targeting PIKfyve-driven lipid metabolism in pancreatic cancer. Nature 642(8068):776\u2013784. https:\/\/doi.org\/10.1038\/s41586-025-08917-z","journal-title":"Nature"},{"issue":"37","key":"12901_CR28","doi-asserted-by":"publisher","first-page":"e01774","DOI":"10.1002\/advs.202501774","volume":"12","author":"S Liu","year":"2025","unstructured":"Liu S, Kang S, Lin N et al (2025) The TET3\/GATA6 Axis Drives Lipid Metabolism and Therapeutic Vulnerabilities in Pancreatic Ductal Adenocarcinoma. Adv Sci (Weinh) 12(37):e01774. https:\/\/doi.org\/10.1002\/advs.202501774","journal-title":"Adv Sci (Weinh)"},{"key":"12901_CR29","doi-asserted-by":"publisher","first-page":"111381","DOI":"10.1016\/j.cellsig.2024.111381","volume":"124","author":"R Cao","year":"2024","unstructured":"Cao R, Feng Z, Mo J et al (2024) Pharmacological inhibition of SREBP1 suppresses pancreatic cancer growth via inducing GPX4-mediated ferroptosis. Cell Signal 124:111381. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111381","journal-title":"Cell Signal"},{"key":"12901_CR30","doi-asserted-by":"publisher","first-page":"101143","DOI":"10.1016\/j.neo.2025.101143","volume":"62","author":"TV Steen","year":"2025","unstructured":"Steen TV, Espinoza I, Duran C et al (2025) Fatty acid synthase (FASN) inhibition cooperates with BH3 mimetic drugs to overcome resistance to mitochondrial apoptosis in pancreatic cancer. Neoplasia 62:101143. https:\/\/doi.org\/10.1016\/j.neo.2025.101143","journal-title":"Neoplasia"},{"issue":"5","key":"12901_CR31","doi-asserted-by":"publisher","first-page":"e2200888","DOI":"10.1002\/smtd.202200888","volume":"7","author":"Y Wang","year":"2023","unstructured":"Wang Y, Chen F, Zhou H et al (2023) Redox Dyshomeostasis with Dual Stimuli-Activatable Dihydroartemisinin Nanoparticles to Potentiate Ferroptotic Therapy of Pancreatic Cancer. Small Methods 7(5):e2200888. https:\/\/doi.org\/10.1002\/smtd.202200888","journal-title":"Small Methods"},{"issue":"8","key":"12901_CR32","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/cac2.70038","volume":"45","author":"M Lao","year":"2025","unstructured":"Lao M, Zhang X, Li Z et al (2025) Lipid metabolism reprograming by SREBP1-PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy. Cancer Commun (Lond) 45(8):1010\u20131037. https:\/\/doi.org\/10.1002\/cac2.70038","journal-title":"Cancer Commun (Lond)"},{"issue":"31","key":"12901_CR33","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1038\/s41388-024-03092-3","volume":"43","author":"MJ Ma","year":"2024","unstructured":"Ma MJ, Shi YH, Liu ZD et al (2024) N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance. Oncogene 43(31):2405\u20132420. https:\/\/doi.org\/10.1038\/s41388-024-03092-3","journal-title":"Oncogene"},{"key":"12901_CR34","doi-asserted-by":"publisher","first-page":"112681","DOI":"10.1016\/j.intimp.2024.112681","volume":"139","author":"Y Lin","year":"2024","unstructured":"Lin Y, Zhang X, Wang Y, Yao W (2024) LPCAT2-mediated lipid droplet production supports pancreatic cancer chemoresistance and cell motility. Int Immunopharmacol 139:112681. https:\/\/doi.org\/10.1016\/j.intimp.2024.112681","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"12901_CR35","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.molmed.2024.03.008","volume":"30","author":"MC De Santis","year":"2024","unstructured":"De Santis MC, Bockorny B, Hirsch E, Cappello P, Martini M (2024) Exploiting pancreatic cancer metabolism: challenges and opportunities. Trends Mol Med 30(6):592\u2013604. https:\/\/doi.org\/10.1016\/j.molmed.2024.03.008","journal-title":"Trends Mol Med"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12901-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12901-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12901-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:26:10Z","timestamp":1791779170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12901-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12901"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12901-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"20 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved the final manuscript and consent to its publication in Molecular Biology Reports.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used publicly available, de-identified data from TCGA, GTEx, and GEO, together with commercially obtained cell lines. No human participants, human tissue specimens, or animals were directly involved. Therefore, ethics approval and informed consent were not required. All public data were collected in accordance with the ethical requirements of the original studies. Consent to participate: not applicable. Clinical trial registration: not applicable.","order":3,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1710"}}